| JYHB2001571 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2020-08-25 | AbbVie Inc | Abbvie Inc | Certificate Issued | 2021-02-25 | view |
| JYHB2000636 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Inc | Abbvie Inc | Filed | 2020-06-09 | view |
| JYHB1900573 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2019-05-27 | AbbVie Inc | Abbvie Inc | Certificate Issued | 2021-02-25 | view |
| JYHB1801470 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2018-12-13 | AbbVie Inc | Abbvie Inc | Filed | 2018-12-19 | view |
| JYHZ1700300 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | License Renew | 2018-01-19 | AbbVie Inc | Abbvie Inc | Certificate Issued | 2018-08-14 | view |
| JXSL1800066 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXHL1700140 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2017-07-31 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-12-20 | view |
| JXHL2100034 | ABBV-744片 | ABBV-744 | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-02-03 | AbbVie Inc. | Abbvie Inc | In Review | 2021-02-03 | view |
| JXHL1500295 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs | Import Drug Application | 2015-12-11 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-08-12 | view |
| JXHL2000262 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
| JXHL1900277 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-10-29 | AbbVie Inc. | Abbvie Inc | In Review | 2019-10-25 | view |
| JXHL1800005 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-01-15 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-06-07 | view |
| JXHL1600128 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2016-11-07 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-05-22 | view |
| JXHL1400106 | ABT-333 Film Coated Tablet | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
| JXHL1900319 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-18 | AbbVie Inc. | Abbvie Inc | In Review | 2019-11-16 | view |
| JXSL1800049 | 输注用无菌冻干粉Telisotuzumab Vedotin | Telisotuzumab Vedotin | Lyophilized | Biological Products | Import Drug Application | 2018-11-15 | AbbVie Inc. | Abbvie Inc | In Review | 2018-11-14 | view |
| JXHL1700079 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-04-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-10-12 | view |
| JYHB1501395 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-09-28 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-25 | view |
| JXHL1900243 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-09-27 | AbbVie Inc. | Abbvie Inc | In Review | 2019-09-26 | view |
| JXSL1700057 | Rovalpituzumab Tesirine | rovalpituzumab tesirine | Other | Biological Products | Import Drug Application | 2017-09-27 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-07-05 | view |
